Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Medicare Part D Payment Model Gives Health Plans More Incentives To Negotiate Lower Drug Prices

21 Jan 2019

• By Brenda Sandburg

Medicare binary sign concept illustration design over black - Vector

Related Content

Trump Drug Pricing Plan Includes Part D Surprises, Challenges PBM Business Model

12 May 2018

CMS To Test Value-Based Insurance Design; Diabetes, COPD Among Target Diseases

24 Sep 2015

Medicare Value-Based Model May Provide Test For Biosimilars – At Some Point

23 Aug 2016

Part D Reform Proposals From MedPAC May Find Traction After Election

16 Jun 2016

Additional Topics

United States Pricing Debate Reimbursement Policy Pricing Strategies Government Payers BioPharmaceutical

More from Medicare

More from Government Payers

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.